Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR)

Historical Holders from Q1 2023 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
MRKR on Nasdaq
Shares outstanding
16,869,505
Price per share
$1.49
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
3,426,371
Total reported value
$3,060,094
% of total 13F portfolios
0%
Share change
-12,700
Value change
-$186,916
Number of holders
31
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
New Enterprise Associates 16, L.P. 9.9% -21% $1,703,483 +$45,291 1,670,081 +2.7% New Enterprise Associates 16, L.P. 13 Nov 2025
Alyeska Investment Group, L.P. 9.9% -0.9% $1,140,560 +$188,135 1,280,952 +20% Alyeska Investment Group, L.P. 30 Sep 2025
Blue Owl Capital Holdings LP 10% +96% $1,160,864 +$589,986 1,127,052 +103% Blue Owl Capital Holdings LP 31 Mar 2025
As of 30 Sep 2025, Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR) has 31 institutional shareholders filing 13F forms. They hold 3,426,371 shares. of 16,869,505 outstanding shares (20%) .

Top 25 institutional shareholders own 20% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
NEA Management Company, LLC 9.6% 1,625,678 0% 0.08% $1,451,080
Blue Owl Capital Holdings LP 3.3% 554,250 0% 0.15% $494,724
Aisling Capital Management LP 1.9% 325,370 0% 0.06% $290,425
VANGUARD GROUP INC 1.8% 299,781 +8.9% 0% $267,704
RENAISSANCE TECHNOLOGIES LLC 0.63% 106,250 +53% 0% $94,840
GEODE CAPITAL MANAGEMENT, LLC 0.57% 96,316 +0.57% 0% $85,988
OSAIC HOLDINGS, INC. 0.48% 81,081 +314% 0% $74,235
LPL Financial LLC 0.35% 58,747 -20% 0% $52,438
Torrey Growth & Income Advisors 0.31% 51,984 0% 0.01% $46,401
TWO SIGMA SECURITIES, LLC 0.28% 47,603 0.01% $42,490
TWO SIGMA INVESTMENTS, LP 0.22% 36,540 0% $32,616
Virtu Financial LLC 0.17% 28,329 0% $25,000
XTX Topco Ltd 0.13% 21,772 0% $19,434
STATE STREET CORP 0.12% 20,948 0% 0% $18,698
Creative Planning 0.1% 17,312 0% 0% $15,453
MATRIX ASSET ADVISORS INC/NY 0.09% 15,000 0% 0% $13,389
NORTHERN TRUST CORP 0.06% 10,857 0% 0% $9,691
Ashton Thomas Private Wealth, LLC 0.06% 10,000 0% $8,926
CITIGROUP INC 0.05% 9,276 0% $8,280
UBS Group AG 0.03% 5,794 +262% 0% $5,174
BANK OF AMERICA CORP /DE/ 0.01% 1,123 +0.81% 0% $1,001
BlackRock, Inc. 0.01% 992 0% 0% $885
MORGAN STANLEY 0% 461 +15% 0% $412
WELLS FARGO & COMPANY/MN 0% 242 +4.3% 0% $216
SBI Securities Co., Ltd. 0% 203 -88% 0% $181

Institutional Holders of Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 73 $109 -$13 $1.49 1
2025 Q3 3,426,371 $3,060,094 -$186,916 $0.89 31
2025 Q2 3,410,487 $5,218,067 -$775,165 $1.53 31
2025 Q1 4,023,536 $4,948,972 +$278,481 $1.23 31
2024 Q4 3,476,245 $10,738,287 +$4,725,531 $3.11 31
2024 Q3 1,936,917 $5,462,150 -$201,925 $2.82 27
2024 Q2 1,938,345 $10,524,473 +$162,843 $5.43 26
2024 Q1 1,911,504 $8,219,717 +$17,150 $4.30 26
2023 Q4 1,906,940 $10,488,483 +$187,945 $5.50 24
2023 Q3 1,871,217 $8,502,131 +$260,999 $4.54 26
2023 Q2 1,824,779 $5,655,903 +$1,085,798 $3.10 27
2023 Q1 1,624,962 $1,154,593 +$1,154,592 $0.71 26